Keynote

Advancing Cancer Research Through Collaborations between Academia, Industry and Regulatory Science
Richard Pazdur, MD, Director, Office of Hematology & Oncology Products, FDA

Main Sessions

Project Data Sphere Initiative Update

• Monica Bertagnolli, MD, Alliance for Clinical Trials in Oncology
• Paul Kluetz, MD, FDA
• Michael Morris, MD, Memorial Sloan Kettering Cancer Center
• Martin Murphy, DMedSc, PhD, FASCO, Project Data Sphere
• Mace Rothenberg, MD, Pfizer Oncology
• Daniel Sargent, Alliance for Clinical Trials in Oncology
• Oliver Sartor, MD, Tulane School of Medicine
• Howard Scher, MD, Memorial Sloan Kettering Cancer Center

FDA’s Information Exchange and Data Transformation (INFORMED) Initiative Update

• Sean Khozin, MD, MPH, FDA
• Geoffrey Kim, MD, FDA

From Silos to Solutions: LSC and NCI/FDA Collaboration

• Sean Khozin, FDA
• Geoffrey Kim, FDA
• Douglas Lowy, National Cancer Institute
• Martin Murphy, DMedSc, PhD, FASCO
• Mace Rothenberg, MD, Pfizer Oncology

Attendees

Astellas

AstraZeneca

Brigham & Women’s/Alliance

C-Change

EMD Serono

Helsinn

HHS

Hogan Lovells

Massachusetts General Hospital

Mayo/Alliance

Merck

MITRE

MSKCC

National Cancer Institute, NIH

Novartis

Patients & Partners, LLC

Pfizer

RTI

Sanofi

SAS

Takeda

Tulane

University of North Carolina